| The potential and controversy of targeting STAT family members in cancer Y Verhoeven, S Tilborghs, J Jacobs, J De Waele, D Quatannens, ... Seminars in cancer biology 60, 41-56, 2020 | 280 | 2020 |
| Cancer-associated fibroblasts as a common orchestrator of therapy resistance in lung and pancreatic cancer A Domen, D Quatannens, S Zanivan, C Deben, J Van Audenaerde, ... Cancers 13 (5), 987, 2021 | 47 | 2021 |
| Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma J Van Loenhout, L Freire Boullosa, D Quatannens, J De Waele, C Merlin, ... Cells 10 (11), 2936, 2021 | 39 | 2021 |
| Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment JRM Van Audenaerde, E Marcq, B von Scheidt, AS Davey, AJ Oliver, ... Clinical & translational immunology 9 (8), e1165, 2020 | 30 | 2020 |
| Targeting hedgehog signaling in pancreatic ductal adenocarcinoma D Quatannens, Y Verhoeven, P Van Dam, F Lardon, H Prenen, G Roeyen, ... Pharmacology & Therapeutics 236, 108107, 2022 | 25 | 2022 |
| The effect of local non‐thermal plasma therapy on the cancer‐immunity cycle in a melanoma mouse model A Lin, J De Backer, D Quatannens, B Cuypers, H Verswyvel, ... Bioengineering & Translational Medicine 7 (3), e10314, 2022 | 16 | 2022 |
| Targeting the PD-1 axis with pembrolizumab for recurrent or metastatic cancer of the uterine cervix: a brief update Y Verhoeven, D Quatannens, XB Trinh, A Wouters, ELJ Smits, F Lardon, ... International journal of molecular sciences 22 (4), 1807, 2021 | 12 | 2021 |
| Therapeutic ROS and Immunity in Cancer—The TRIC-21 Meeting S Bekeschus, S Emmert, R Clemen, L Boeckmann Cancers 13 (18), 4549, 2021 | 2 | 2021 |
| IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts A Van den Eynde, L Gehrcken, T Verhezen, HW Lau, C Hermans, ... Journal of Hematology & Oncology 17 (1), 1-19, 2024 | | 2024 |
| Kankergeassocieerde fibroblasten dragen bij tot therapieresistentie in long-en pancreaskanker A Domen, D Quatannens, H Prenen Bloedvaten, hart, longen.-Kraainem 26 (6), 32-36, 2021 | | 2021 |
| Les fibroblastes associés au cancer favorisent la résistance à la thérapie en cas de cancers du poumon et du pancréas A Domen, D Quatannens, H Prenen Vaisseaux, coeur, poumons.-Kraainem: Reflexion Medical Network, 1996 26 (6 …, 2021 | | 2021 |
| 453 Novel combination immunotherapy for boosting and priming immune responses in pancreatic cancer: strong anti-tumour effects with interleukin-15 and CD40 agonist treatment J Van Audenaerde, E Marcq, B von Scheidt, A Davey, A Oliver, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
